366 related articles for article (PubMed ID: 32655532)
1. Biocides and Novel Antimicrobial Agents for the Mitigation of Coronaviruses.
Dev Kumar G; Mishra A; Dunn L; Townsend A; Oguadinma IC; Bright KR; Gerba CP
Front Microbiol; 2020; 11():1351. PubMed ID: 32655532
[TBL] [Abstract][Full Text] [Related]
2. Viral Inactivation with Emphasis on SARS-CoV-2 Using Physical and Chemical Disinfectants.
Fadaei A
ScientificWorldJournal; 2021; 2021():9342748. PubMed ID: 34712107
[TBL] [Abstract][Full Text] [Related]
3. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
Bchetnia M; Girard C; Duchaine C; Laprise C
J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of Peracetic Acid and Sodium Hypochlorite against SARS-CoV-2 on Contaminated Surfaces.
Morris JN; Esseili MA
Appl Environ Microbiol; 2023 Jul; 89(7):e0062223. PubMed ID: 37347194
[TBL] [Abstract][Full Text] [Related]
5. Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses.
Jaimes JA; André NM; Millet JK; Whittaker GR
bioRxiv; 2020 Feb; ():. PubMed ID: 32511311
[TBL] [Abstract][Full Text] [Related]
6. Molecular Insights Into SARS COV-2 Interaction With Cardiovascular Disease: Role of RAAS and MAPK Signaling.
Wehbe Z; Hammoud S; Soudani N; Zaraket H; El-Yazbi A; Eid AH
Front Pharmacol; 2020; 11():836. PubMed ID: 32581799
[TBL] [Abstract][Full Text] [Related]
7. Coronavirus Disease 2019: Coronaviruses and Blood Safety.
Chang L; Yan Y; Wang L
Transfus Med Rev; 2020 Apr; 34(2):75-80. PubMed ID: 32107119
[TBL] [Abstract][Full Text] [Related]
8. Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses.
Artese A; Svicher V; Costa G; Salpini R; Di Maio VC; Alkhatib M; Ambrosio FA; Santoro MM; Assaraf YG; Alcaro S; Ceccherini-Silberstein F
Drug Resist Updat; 2020 Dec; 53():100721. PubMed ID: 33132205
[TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2: An Update on Potential Antivirals in Light of SARS-CoV Antiviral Drug Discoveries.
Elshabrawy HA
Vaccines (Basel); 2020 Jun; 8(2):. PubMed ID: 32585913
[TBL] [Abstract][Full Text] [Related]
10. The New Coronavirus COVID-19 Infection.
Bevova MR; Netesov SV; Aulchenko YS
Mol Gen Microbiol Virol; 2020; 35(2):53-60. PubMed ID: 32929302
[TBL] [Abstract][Full Text] [Related]
11. A Coronavirus Disease 2019 (COVID-19) Patient with Multifocal Pneumonia Treated with Hydroxychloroquine.
Mukherjee A; Ahmad M; Frenia D
Cureus; 2020 Mar; 12(3):e7473. PubMed ID: 32351851
[TBL] [Abstract][Full Text] [Related]
12. Povidone-Iodine Use in Sinonasal and Oral Cavities: A Review of Safety in the COVID-19 Era.
Frank S; Capriotti J; Brown SM; Tessema B
Ear Nose Throat J; 2020 Nov; 99(9):586-593. PubMed ID: 32520599
[TBL] [Abstract][Full Text] [Related]
13. Current coronavirus (SARS-CoV-2) epidemiological, diagnostic and therapeutic approaches: An updated review until June 2020.
Nabil A; Uto K; Elshemy MM; Soliman R; Hassan AA; Ebara M; Shiha G
EXCLI J; 2020; 19():992-1016. PubMed ID: 32788913
[TBL] [Abstract][Full Text] [Related]
14. Potential Maternal and Infant Outcomes from (Wuhan) Coronavirus 2019-nCoV Infecting Pregnant Women: Lessons from SARS, MERS, and Other Human Coronavirus Infections.
Schwartz DA; Graham AL
Viruses; 2020 Feb; 12(2):. PubMed ID: 32050635
[TBL] [Abstract][Full Text] [Related]
15. A Comparative Study on Virology, Epidemiology, and Clinical Features of SARS and COVID-19.
Zhao Y; Lu Q; Meng X; Huang S; Zhang J; Dong W; Fan H; Hou S
Disaster Med Public Health Prep; 2021 Aug; 17():e35. PubMed ID: 34462042
[TBL] [Abstract][Full Text] [Related]
16. COVID-19: A Worldwide, Zoonotic, Pandemic Outbreak.
Khan T; Agnihotri K; Tripathi A; Mukherjee S; Agnihotri N; Gupta G
Altern Ther Health Med; 2020 Aug; 26(S2):56-64. PubMed ID: 32412918
[TBL] [Abstract][Full Text] [Related]
17. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges.
Lai CC; Shih TP; Ko WC; Tang HJ; Hsueh PR
Int J Antimicrob Agents; 2020 Mar; 55(3):105924. PubMed ID: 32081636
[TBL] [Abstract][Full Text] [Related]
18. Recommendations on the clinical management of the COVID-19 infection by the «new coronavirus» SARS-CoV2. Spanish Paediatric Association working group.
Calvo C; López-Hortelano MG; Vicente JCC; Martínez JLV;
An Pediatr (Engl Ed); 2020 Apr; 92(4):241.e1-241.e11. PubMed ID: 32341943
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Povidone-Iodine Nasal and Oral Antiseptic Preparations Against Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2).
Pelletier JS; Tessema B; Frank S; Westover JB; Brown SM; Capriotti JA
Ear Nose Throat J; 2021 Apr; 100(2_suppl):192S-196S. PubMed ID: 32951446
[TBL] [Abstract][Full Text] [Related]
20. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
Liu J; Zheng X; Tong Q; Li W; Wang B; Sutter K; Trilling M; Lu M; Dittmer U; Yang D
J Med Virol; 2020 May; 92(5):491-494. PubMed ID: 32056249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
